Eli Lilly and Co
1LLY
Company Profile
Business description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Contact
Lilly Corporate Center
IndianapolisIN46285
USAT: +1 317 276-2000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
47,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,637.50 | 22.80 | -0.26% |
| CAC 40 | 7,737.20 | 14.69 | -0.19% |
| DAX 40 | 23,930.67 | 66.81 | -0.28% |
| Dow JONES (US) | 42,173.80 | 96.27 | -0.23% |
| FTSE 100 | 8,774.26 | 1.88 | 0.02% |
| HKSE | 23,157.97 | 131.80 | -0.57% |
| NASDAQ | 19,199.05 | 85.29 | 0.45% |
| Nikkei 225 | 37,470.67 | 494.43 | -1.30% |
| NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
| S&P 500 | 5,919.22 | 7.53 | 0.13% |
| S&P/ASX 200 | 8,414.10 | 20.60 | -0.24% |
| SSE Composite Index | 3,347.49 | 15.96 | -0.47% |